Icahn School Of Medicine At Mount Sinai

Exposure to certain air pollutant mixtures appeared significantly associated with more severe asthma in children, according to results of a machine learning-based analysis published in The Journal of Clinical Investigation.

Cognitive impairment occurred relatively often within several months of patients having had COVID-19, according to results of a cross-sectional study published in JAMA Network Open.

Among more than 2 million women in Sweden, preterm delivery yielded a significantly increased risk for future chronic hypertension, an association that persisted at least 40 years later, according to data published in JAMA Cardiology.

LAS VEGAS – Resiliency, respect and relationships allowed the ACG to thrive during the pandemic, pushed the careers of its leaders forward and brought the association back to in-person meetings.

Edoxaban (Savaysa, Daiichi Sankyo) or vitamin K antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement.

Messaging built into an existing electronic health records system to directly connect physicians may increase screening and diagnosis of familial hypercholesterolemia among patients identified as being high risk, a speaker reported.

The addition of pembrolizumab to first-line chemotherapy led to statistically significant improvement in PFS and OS among patients with PD-L1-positive metastatic triple-negative breast cancer, according to results of the KEYNOTE-355 trial.

Two years of abiraterone acetate plus prednisolone-based therapy significantly improved survival among men with high-risk nonmetastatic prostate cancer starting androgen deprivation therapy, according to results of the STAMPEDE trial.

Adding abiraterone acetate to androgen deprivation therapy plus docetaxel improved radiographic PFS and OS among men with metastatic castration-sensitive prostate cancer, according to data presented during the virtual ESMO Congress 2021.

Patients with pretreated locally advanced or metastatic HER2-positive breast cancer had significantly longer PFS after treatment with [vic-]trastuzumab duocarmazine vs. physician’s choice of treatment, according to study results.